GeneSystem Co

GeneSystem Co Days Inventory Outstanding

The Days Inventory Outstanding (DIO) of GeneSystem Co (363250.KQ) as of Nov 4, 2026 is 83.17. In the previous year, Days Inventory Outstanding (DIO) was 397.73 — a change of -79.09% (lower).

Days Inventory Outstanding

83.17

YoY

-79.09%

Last updated:

Days Inventory Outstanding (DIO) of GeneSystem Co is 2025 83.17 . Days Inventory Outstanding (DIO) of GeneSystem Co was 2024 397.73 . It decreases by -79.09% lower compared to the previous year.

The GeneSystem Co Days Inventory Outstanding history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Days Inventory Outstanding
Date
Days Inventory Outstanding
Jan 1, 2018
196.09 KRW
Jan 1, 2019
150.29 KRW
Jan 1, 2020
114.34 KRW
Jan 1, 2021
123.07 KRW
Jan 1, 2022
469.09 KRW
Jan 1, 2023
582.80 KRW
Jan 1, 2024
397.73 KRW
Jan 1, 2025
83.17 KRW
The GeneSystem Co Days Inventory Outstanding history
YEARDays Inventory OutstandingYoY
83.17-79.09%
397.73-31.76%
582.80+24.24%
469.09+281.16%
123.07+7.63%
114.34-23.92%
150.29-23.36%
196.09—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

GeneSystem Co Stock analysis

What does GeneSystem Co do? GeneSystem Co., Ltd generates revenue through the development, manufacturing, and sale of PCR-based molecular diagnostic products. The company offers molecular diagnosis systems, biochips, test kits, and reaction reagents, targeting healthcare providers and laboratories seeking advanced in vitro diagnostic solutions. Its core business focuses on molecular diagnosis technology, complementing immunodiagnosis technology to deliver comprehensive diagnostic tools. The firm serves medical institutions requiring precise and efficient diagnostic equipment for disease detection and monitoring. The company's product portfolio includes platform-based molecular diagnostic systems, biochips, and test kits designed for laboratory use. These products are sold directly to healthcare facilities and diagnostic laboratories, supporting applications in infectious disease testing and genetic analysis. By leveraging its expertise in molecular diagnosis, GeneSystem Co., Ltd provides essential tools for medical professionals to enhance diagnostic accuracy and patient care. GeneSystem Co., Ltd's revenue streams are derived from the sale of diagnostic systems, biochips, and consumables such as test kits and reaction reagents. The firm's target market comprises healthcare institutions and laboratories that require reliable in vitro diagnostic technology. The company's focus on molecular diagnosis technology positions it as a key supplier in the diagnostic equipment sector, meeting the growing demand for advanced diagnostic solutions in healthcare. GeneSystem Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about GeneSystem Co stock

Days Inventory Outstanding (DIO) of GeneSystem Co is 83.17 in 2025.

Days Inventory Outstanding (DIO) of GeneSystem Co changed from 397.73 to 83.17, representing a -79.09% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Days Inventory Outstanding (DIO) GeneSystem Co since 2006 – with annual values, charts, and detailed analysis.

DIO measures the average number of days inventory is held before being sold. Lower values indicate more efficient inventory management.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Days Inventory Outstanding (DIO)'s GeneSystem Co with sector peers and the industry average to assess whether it is attractive.

To evaluate Days Inventory Outstanding (DIO)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Days Inventory Outstanding (DIO).

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Profitability — GeneSystem Co

All Key Metrics — GeneSystem Co